We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
SLB Ltd
SLB
$78.4B
| $2.04M | 0.01% |
24,282
-32,764
| -57% | -$2.69M |
|
327
Huntsman Corp
HUN
$2.24B
| $2.02M | 0.01% |
105,752
-23,249
| -18% | -$422K |
|
|
SGBK
328
DELISTED
Stonegate Bank
SGBK
| $2M | 0.01% |
48,043
-5,000
| -9% | -$189K |
|
329
Boeing
BA
$165B
| $2M | 0.01% |
12,821
+312
| +2% | +$45.6K |
|
330
Onto Innovation
ONTO
$13.6B
| $1.99M | 0.01% |
79,400
-1,000
| -1% | -$22.9K |
|
331
Costco
COST
$415B
| $1.97M | 0.01% |
12,314
-2,462
| -17% | -$376K |
|
332
SPDR Gold Trust
GLD
$131B
| $1.94M | 0.01% |
17,736
-1,113
| -6% | -$129K |
|
333
Target
TGT
$62.1B
| $1.94M | 0.01% |
26,902
-11,127
| -29% | -$805K |
|
334
White Mountains Insurance
WTM
$5.47B
| $1.94M | 0.01% |
2,318
| – | – |
|
335
Lockheed Martin
LMT
$134B
| $1.94M | 0.01% |
7,742
-644
| -8% | -$161K |
|
|
GIMO
336
DELISTED
Gigamon Inc.
GIMO
| $1.92M | 0.01% |
42,100
-1,000
| -2% | -$52K |
|
337
TTEC Holdings
TTEC
$103M
| $1.91M | 0.01% |
62,758
-171,438
| -73% | -$4.93M |
|
|
AGR
338
DELISTED
Avangrid, Inc.
AGR
| $1.9M | 0.01% |
50,096
-2,400
| -5% | -$91.6K |
|
|
WGL
339
DELISTED
Wgl Holdings
WGL
| $1.89M | 0.01% |
24,800
-2,700
| -10% | -$182K |
|
340
Molson Coors Class B
TAP
$7.68B
| $1.88M | 0.01% |
19,335
+1,095
| +6% | +$112K |
|
341
CME Group
CME
$92.2B
| $1.87M | 0.01% |
16,230
| – | – |
|
342
DuPont de Nemours
DD
$18.6B
| $1.87M | 0.01% |
12,901
-508
| -4% | -$70.7K |
|
343
Viatris
VTRS
$20.1B
| $1.77M | 0.01% |
46,300
-21,800
| -32% | -$810K |
|
|
CSS
344
DELISTED
CSS Industries, Inc.
CSS
| $1.75M | 0.01% |
64,805
+13,650
| +27% | +$359K |
|
|
BBU
345
DELISTED
Brookfield Business Partners
BBU
| $1.75M | 0.01% |
113,296
-3,459
| -3% | -$54.5K |
|
|
TIF
346
DELISTED
Tiffany & Co.
TIF
| $1.73M | 0.01% |
22,353
-3,375
| -13% | -$260K |
|
|
MJN
347
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.72M | 0.01% |
24,346
-357
| -1% | -$26.6K |
|
348
Stanley Black & Decker
SWK
$14.2B
| $1.72M | 0.01% |
14,990
-425
| -3% | -$50.6K |
|
349
Univest Financial
UVSP
$1.23B
| $1.72M | 0.01% |
55,645
-3,997
| -7% | -$107K |
|
|
WMAR
350
DELISTED
West Marine Inc
WMAR
| $1.72M | 0.01% |
164,100
-2,000
| -1% | -$18.3K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.